Loading…
Lobbying Spend
—
Filings
12
Firms Hired
1
Active Period
2024–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA); H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for Biomedical Advanced Research and Development Authority (BARDA) and Project BioShield FY24; H.R. 10545, the American Relief Act, 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 10545
Source: Senate LDA